Review
Published on 10 Jan 2024
Long-term response to sequential anti-HER2 therapies including trastuzumab-deruxtecan in a patient with HER2-positive metastatic breast cancer with leptomeningeal metastases: a case report and review of the literature
in Neuro-Oncology and Neurosurgical Oncology
- 5,006 views
- 4 citations






